5 Side Hustles To Make $1,000/Month From Home In 2025
Your 9-5 job, on its own, won't make you rich. Not in 2025.
So stop expecting it to.
All these factors make side hustles absolutely essential for any professional in 2025 and beyond. The traditional idea of holding down one job to make enough money to live comfortably simply isn't cutting it anymore.
Are Side Hustles Worth It?
A recent survey of 1,000 U.S.-based full-time Gen Z professionals conducted by Resume Genius discovered that:
Millennial professionals are also feeling the financial pinch, so badly, that more than 50% are taking on side hustles while at work, the Hill reported, referring to the findings of a recent study from Academized.com, which surveyed 2,500 millennials aged 26 to 41.
What Are The Best Side Hustles To Make $1,000 From Home?
Here are some high-paying side hustle ideas that are easy to set up and implement almost right away, and can see you earning $1,000 or more a month, purely through your existing skills (so minimal set-up or extra training required, depending on your field):
Quick overview:
How Do I Start A Side Hustle With No Experience?
To start a side hustle from scratch, even if you have limited business experience or feel a little apprehensive about starting one, here's what you need to do, step by step:
So here's what you need to commit to now:
Pick one side hustle idea listed above, or find another one that resonates with you. Stick with it. Don't jump around trying multiple things at the same time, definitely not now, because you'll slow yourself down with overwhelm and get nowhere.
Pay special attention to the skills you already use every day at work; they could be a hidden ... More goldmine of extra income
Follow the step-by-step checklist above and you'll no longer be tied to your paycheck to survive. You can really experience financial freedom outside of your 9-5.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Takeda Pharma Maintains Outlook Even As Vyvanse Generics Hit Sales
Takeda Pharmaceutical Company Limited (NYSE:TAK) posted a strong first-quarter performance for 2025 on Wednesday, with a net profit of 124.2 billion Japanese yen (approximately $834.08 million), reflecting a notable 30.4% year-over-year increase. The company reported earnings per American Depositary Share (EPADS) of 52 cents, surpassing analyst expectations of 47 cents. However, in yen terms, earnings per share (EPS) experienced a 14.1% decline, or a 10% decrease when adjusted for constant currency, reaching 151 yen. Total sales for the quarter amounted to $7.66 billion (1.11 trillion yen), exceeding consensus estimates of $7.53 billion. Despite this positive top-line performance, Takeda faced challenges on the bottom line, with core net profit dropping by 14.4% (or 10.3% at constant currency) to 237 billion key factor behind this decline was the significant erosion of revenue from Vyvanse, its attention-deficit hyperactivity disorder (ADHD) treatment, following the introduction of generic competition. This decline was anticipated by the company and was a major contributor to both the revenue drop and a reduction in core operating profit. View more earnings on TAK U.S. sales of Vyvanse fell 53.8% at constant exchange rates, dropping to 57.9 billion yen. The generics' market entry led to an overall sales decline of 46.9% for the drug during the quarter. On a more positive note, Takeda's portfolio of rare disease treatments showed resilience. Sales of Takhzyro, a treatment for hereditary angioedema, rose by 3.7% to 55.1 billion yen. Immunoglobulin sales also saw growth, increasing 2% at constant currency to 194 billion yen, while Albumin sales surged 16.2%, reaching 32.2 billion yen. In the vaccine segment, Takeda's Qdenga dengue vaccine experienced a 4.8% decline in sales at constant currency, amounting to 8.8 billion yen. However, the oncology division performed solidly, with Adcetris sales climbing 13.2% to 37.2 billion yen, while Fruzaqla, a novel therapy for certain cancers, saw a more modest growth of 8.9%, reaching 12.3 billion yen. Takeda's operating profit for the quarter rose 11% to 184.6 billion yen, while core operating profit dropped 15.8% (down 11.9% on a constant currency basis) to 321.8 billion yen. This decrease was primarily due to lower year-over-year impairment and restructuring expenses. Milano Furuta, Takeda's CFO, commented on the results, noting, 'The impact of Vyvanse generic erosion on Takeda's FY2025 Q1 results was very significant, but consistent with our expectations, and there is no change to our full-year outlook announced in May.' Outlook Takeda reaffirms its fiscal 2025 guidance, with core revenue of 4.53 trillion yen and core operating profit broadly flat at 1.14 trillion yen, and core earnings of 485 yen. Price Action: TAK stock is trading lower by 4.99% to $13.61 at last check Wednesday. Read Next:Photo by Veroniksha via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Takeda Pharma Maintains Outlook Even As Vyvanse Generics Hit Sales originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
an hour ago
- Business Wire
Westlake Chemical Partners LP Announces Second Quarter 2025 Distribution
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 44th quarterly distribution announced by the Partnership since its initial public offering. The distribution will be payable on August 27, 2025, to unit holders of record on August 12, 2025. This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate. About Westlake Chemical Partners LP Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets include three facilities in Calvert City, Kentucky, and Lake Charles, Louisiana which process ethane and propane into ethylene, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit
Business Wire
3 hours ago
- Business Wire
USA TODAY Network and Perplexity Announce Strategic AI Content Licensing Agreement
NEW YORK, NY--(BUSINESS WIRE)-- Gannett Co., Inc. (NYSE:GCI) today announced a strategic deal with Perplexity, the AI-powered answer engine, to license content from USA TODAY and the USA TODAY Network of over 200 local publications across the country. As part of this agreement, Gannett joins the Perplexity Publisher Program as one of the largest U.S.-based media partners. Gannett's premium content and trusted journalism from USA TODAY and top-tier local USA TODAY Network publications will be integrated into Perplexity's AI-powered search experiences, including its newly released agentic web browser, Comet currently available to Perplexity Max and select Perplexity Pro subscribers. Perplexity's Comet is an AI-powered web browser which integrates Perplexity's AI search engine directly into the browsing experience. Beginning in September, Perplexity's Comet is expected to be available for a broader audience. 'As the largest local-to-national publishing and digital media organization in the country, the USA TODAY Network is focused on delivering innovation that drives audience engagement. As AI technology becomes increasingly integrated into the information ecosystem, we are committed to ensuring that our content is properly attributed and that we are fairly compensated,' said Michael Reed, Gannett Chairman and Chief Executive Officer. 'This strategic alliance with Perplexity exemplifies our continued leadership in embracing transformative technology and reflects our belief that innovation and responsible stewardship must go hand in hand, setting a standard for the way quality content and trusted journalism should be valued. This deal allows us to further accelerate AI opportunities as we share advertising revenue and leverage data to deliver shareholder value while providing credible content for users of the Perplexity platform.' 'Gannett's commitment to credible, authoritative reporting makes them an ideal partner as we work to elevate the information landscape,' said Aravind Srinivas, Co-Founder and CEO at Perplexity. 'We strongly believe the opportunity for AI is to elevate the kind of excellent journalism that Gannett's reputation is founded on. As AI reshapes a digital landscape that was optimized for a different era, our priority is to partner with the world's best publishers to ensure they benefit from the new business models we discover together.' Gannett will also have access to Perplexity technology including Perplexity's Sonar API and Perplexity Enterprise Pro for all employees. The financial terms of the deal are not being disclosed. AI companies interested in learning how Gannett | USA TODAY Network can support their strategic efforts should contact gannettinfo@ ABOUT GANNETT Gannett Co., Inc. is a diversified media company with expansive reach at the national and local level dedicated to empowering and enriching communities. We seek to inspire, inform, and connect audiences as a sustainable, growth focused media and digital marketing solutions company. Through our trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including our network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, we provide essential journalism, local content, and digital experiences to audiences and businesses. We deliver high-quality, trusted content with a commitment to balanced, unbiased journalism, where and when consumers want to engage. Our digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with innovative digital marketing products and solutions. Perplexity is an AI-powered answer engine that draws from credible sources in real time to accurately answer questions with in-line citations, perform deep research, and more. Founded in 2022, the company's mission is to serve the world's curiosity by bridging the gap between traditional search engines and AI-driven interfaces. Each week, Perplexity answers more than 150 million questions globally. Perplexity is available in the app store and online at Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that relate to our current expectations and views of future events, which may include but not be limited to all statements other than statements of historical facts contained in this press release, including statements relating to the strategic affiliation and our beliefs, intentions, estimates or strategies regarding the future, which may not be realized. In some cases, you can identify forward-looking statements by terms such as 'believe,' 'may,' 'estimate,' 'continue,' 'anticipate,' 'intend,' 'should,' 'plan,' 'expect,' 'predict,' 'potential,' 'could,' 'will,' 'would,' 'ongoing,' 'future' or the negative of these terms or other similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are based largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements involve known and unknown risks, uncertainties, contingencies, changes in circumstances that are difficult to predict and other important factors that may cause our actual results, performance, or achievements to be materially and/or significantly different from any future results, performance or achievements expressed or implied by the forward-looking statement. For a discussion of some of the risks and important factors that could cause actual results to differ materially from our expectations, see the risks and other factors detailed in 'Item 3. Key Information - Risk Factors' in Gannett's 2024 Annual Report on Form 10-K and Gannett's quarterly reports on Form 10-Q and Gannett's other filings with the SEC, in each case as such factors may be updated from time to time. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Gannett disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.
